The pharmaceutical landscape is undergoing a seismic shift. If you looked at the top-selling drugs twenty years ago, you’d find mostly "small molecule" pills, aspirin, statins, and Ibuprofen. Today, the leaderboard is dominated by biologics. These complex, large-molecule therapies derived from living organisms are treating previously "untreatable" diseases, from chronic autoimmune...
The global Biotherapeutics Cell Line Development Market is experiencing substantial growth as biopharmaceutical companies increasingly focus on developing innovative biologics, biosimilars, monoclonal antibodies, vaccines, and gene therapies. Cell line development serves as a critical step in biotherapeutic manufacturing, enabling the production of high-quality and high-yield biologic products....
The global biopharmaceutical industry is undergoing a transformative shift as biologics continue to dominate drug pipelines and therapeutic innovations. In this evolving ecosystem, Biologics Contract Development and Manufacturing Organizations (CDMOs) play a critical role by providing specialized services that support the development, production, and commercialization of complex biologic drugs....
“According to a new report published by Introspective Market Research, the Bioprocess Containers Market by Product Type, Material, and End User, the Global Bioprocess Containers Market Size was Valued at USD 2.14 Billion in 2023 and is Projected to Reach USD 4.18 Billion by 2032, Growing at a CAGR of 12.2%.”
The bioprocess containers market plays a vital role in modern...
According to a newly published market research report by 24LifeSciences, global cGMP Process Development market was valued at USD 3.75 billion in 2025 and is projected to reach USD 6.06 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 2025–2032.
cGMP process development represents the critical discipline of systematically designing,...
Regulatory complexity in drug manufacturing is encouraging companies to rely on specialized CDMOs.Expert compliance management reduces operational risks and delays.This support is critical for global market expansion.
Active Pharmaceutical Ingredients CDMO market The market is expected to grow steadily at a CAGR of 7.4% from 2025 to 2031, driven by innovation in drug development and the global...
About SPORTIVO Network
Czech
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Russian
Romaian
Portuguese (Brazil)
Greek